Novartis Ag

Hans-Peter Knopf

Thomas Jostock

Burkhard Wilms

Daniel Huang

Jean-Michel Rene Rondeau

Gino Van Heeke

Nicole Haubst

Danforth Miller

Kapil Gupta

Matthew John Edwards

Barbara Andlauer

Audrey Nommay

Yehuda G Assaraf

Rene Hemmig

Michael Otto Bardroff

Jiri Kovarik

Christian Graf

Maximilian Woisetschlaeger

Rolf Koehler

Tina Buch

Daniel Heitmann

Dhavalkumar Patel

Stephen John Oliver

Audrey Josiane Nommay

The invention relates to bivalent bispecific monoclonal antibodies (bbmAb) or variants thereof, and methods of manufacturing such antibodies by co-expressing modified Fc-mutated derivatives of two different monoclonal antibodies in mammalian cell lines.

Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodies

The disclosure is directed to an expression vector or a combination of at least two expression vectors for producing a polypeptide of interest, the vector or vectors comprising a polynucleotide encoding a mutated folate receptor as a selectable marker. The disclosure also relates to host cells, selection methods and methods for producing polypeptides with high yield.

Selection vectors and methods of selecting eukaryotic host cells

The invention provides vector nucleic acid for expressing at least one polypeptide of interest in a mammalian cell, comprising

Mammalian expression vector

The invention pertains to an expression vector or a combination of at least two expression vectors comprising at least

Expression vector system comprising two selection markers

The present invention relates to a novel selection system for use in a eukaryotic cell culture process and for expression of a recombinant product of interest. The selection system is based on the introduction of an exogenous functional membrane-bound folate receptor gene together with the polynucleotide or gene encoding the product of interest into a eukaryotic cell and can be widely utilized with eukaryotic cells for which cellular viability is dependent upon folic acid uptake.

Organic compounds

The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.

Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules

A method for selecting mammalian host cells that express a polypeptide of interest with high yield is described. The host cells comprise an expression cassette comprising at least a first polynucleotide encoding the polypeptide of interest, at least one leaky stop codon downstream of the first polynucleotide, and a second polynucleotide downstream of the leaky stop codon encoding an immunoglobulin transmembrane anchor. The host cells are cultivated to allow expression of the polypeptide of interest such that at least a portion of the polypeptide of interest is expressed as a fusion polypeptide that is displayed on the cell surface. The cells are selected based upon the presence or amount of the displayed fusion polypeptide. Also provided are methods for producing a polypeptide that employ a respective selection to identify high expressing host cells.

Cell surface display of polypeptide isoforms by stop codon readthrough

The application describes a method of selecting mammalian host cells that express a polypeptide of interest with high yield. The host cells contain an expression cassette with a first polynucleotide encoding a polypeptide of interest, at least one leaky stop codon located downstream of the first polynucleotide and a second polynucleotide located downstream of the leaky codon encoding an immunoglobulin transmembrane anchor comprising a cytoplasmic domain. The host cells are cultivated to allow expression of the polypeptide of interest such that some of the polypeptides of interest are expressed as fusion proteins displayed on the cell surface. High producing cells are then selected based on the presence or amount of the displayed fusion polypeptides.

The invention provides vector nucleic acid for expressing at least one polypeptide of interest in a mammalian cell, comprising Also provided are host cells, comprising said vector and methods for producing a polypeptide using respective host cells.

The present invention pertains to a method for selecting at least one eukaryotic host cell expressing a product of interest. The method entails providing a plurality of host cells which are dependent upon folate uptake and contain polynucleotides encoding for the product of interest and a DHFR enzyme. The cells are cultured in a selective culture medium containing at least an inhibitor of DHFR and folate. The expressed cells are then selected.

Methods for selecting eukaryotic cells expressing a heterologous protein

The invention pertains to a method for selecting at least one eukaryotic host cell expressing a product of interest, comprising Also provided is a method for expressing a product of interest which is based on host cells selected by said method and a cell culture medium.

Growing community of inventors

Schallstadt, Germany

Hans-Peter Knopf